Sen. Josh Hawley launched an investigation into abortion drug manufacturers
NEWNow you can listen to Fox News articles!
Sen. Josh Hawley, R-Mo., launched an investigation into two manufacturers of mifepristone that he says profited from the abortion drug despite evidence that it “poses significant risks to women.”
Hawley named the two companies, Danco Laboratories and GenBioPro, in letters to company executives obtained by Fox News Digital. These letters inform company executives that he is opening an investigation by the Senate Judiciary Subcommittee on Crime and Counterterrorism, which he chairs.
“Overwhelming evidence shows that mifepristone poses serious risks to women. Yet your company has continued to benefit from the widespread distribution of this drug even as serious questions have arisen about bleeding, infection, sepsis, and other dangerous complications associated with its use,” Hawley wrote to both companies.
“Congress must determine what your company knew about mifepristone-related harm, when it knew it, what it told regulators, and what it may have failed to disclose to women and the public,” she added.
PRO-LIFE GROUP TALKS TO SENANA TO PRESSURE RFK JR. ON THE SAFETY OF THE ABORTION PILL, DEMAND THE RETURN OF PROTECTION
Sen. Josh Hawley, Republican of Missouri, asked Dr. Verma whether men can get pregnant during the hearing on Wednesday. (Valerie Plesch/Bloomberg via Getty Images)
The letters require the companies to share documents related to the investigation by April 24.
Those documents include all adverse event reports related to mifepristone, relevant internal databases and a list of other documents.
Neither company immediately responded to a request for comment from Fox News Digital.
The investigation comes about a week after Hawley introduced a new bill to revoke the FDA’s approval of mifepristone.
A container carrying boxes of mifepristone, the first medical abortion drug, is prepared for patients at the Alamo Women’s Clinic in Carbondale, Illinois, on April 20, 2023. (Evelyn Hockstein/Reuters)
The new bill builds on proposed legislation Hawley introduced last year that would have banned mifepristone and allowed women to sue manufacturers who profit from what the lawmaker sees as an “inherently dangerous” drug.
The Safeguarding Women from Chemical Abortion Act was introduced in the Senate on Tuesday and would ban the use of mifepristone to terminate pregnancies.
SOUTH CAROLINA LEGISLATORS INTRODUCE BILL TO MURDER AS MURDER.
“The science is clear: The chemical abortion drug is inherently dangerous to women and is often abused. Yet big companies like Danco Laboratories make billions off it,” Hawley told Fox News Digital in a statement. “That’s why I’m introducing something new prohibition of use of mifepristone for abortion and give women the power to sue its manufacturers. Congress must act now to protect the health and safety of women.”
An ad in Florida links the abortion drugs mifepristone and misoprostol. (Courtesy: 40 Days to Live)
If passed, this law will be repealed FDA approval with the drug and classify its distribution for abortion as a violation of federal law. By 2023, mifepristone was used in 63% of all abortions in the US, according to data from the Guttmacher Institute.
The Guttmacher Institute, a nonprofit research organization formerly affiliated with Planned Parenthood, also estimates that there will be 1,038,100 abortions performed by doctors in 2024. However, that figure only counts states without abortion bans and does not include abortions performed outside the official health care system or in states where abortion laws are different.
Hawley raised concerns about the abortion pill last May when he introduced a separate bill that would have directed the FDA to create safeguards for mifepristone, allowing women with erectile dysfunction the right to sue health care providers and pharmacies for damages.
A study by the Ethics and Public Policy Center (EPPC) in Washington, DC, showed the level side effects when using mifepristone it is 22 times higher than the indications from the drug label approved by the FDA.
CLICK HERE TO DOWNLOAD THE FOX NEWS PROGRAM
The study revealed that more than one in 10 women reported “an infection, bleeding, or other serious or life-threatening event.”
READ BOOKS ON DANCO LABS AND GENBIOPRO – APP USERS, CLICK HERE AND HERE:
Fox News’ Preston Mizell contributed to this report.
